Sort by
Refine Your Search
-
Program
-
Field
-
Multiple Long-Term Conditions (MLTCs). It has a particular focus on research that is highly relevant to disadvantaged communities who are most impacted by MLTCs. It is led by a multidisciplinary team of
-
sequencing (NGS), and bioinformatics analysis is highly desirable. You will join a multidisciplinary team of approximately 15 experienced chemists, chemical biologists, and molecular/cell biologists based in
-
Researcher with a background in cancer genomics to implement a next-generation sequencing (NGS) assay for the detection of gene abnormalities in samples from patients with acute lymphoblastic leukaemia. You
-
interest. Research over the last 20 years using genetic markers such as microsatellites and mitochondrial gene sequencing has revealed much about the history of divergence among lineages and patterns
-
Experience Research interests and skills closely aligned with the project aim of investigating health outcomes for vulnerable patient groups Experience of working directly with vulnerable patient groups
-
and interpretation of results Supporting the analysis of multiple mitochondrial ‘omics datasets, such genomics, transcriptomics and clinical data Collaborating regularly with the team members and
-
. The RELMED study is currently in the set-up phase. It consists of two randomised clinical trials to be run in sequence. The first trial will start early 2025 to 2027. This will be followed by a second trial to
-
collaborative project that spans multiple continents. You will contribute to the development of new chronobiological analytics on existing data, design experiments to collect novel chronobiological data, engage
-
Attributes and Behaviour Ability to negotiate and prioritise multiple, competing responsibilities and to work to deadlines Be open to new ideas, and welcome different perspectives and new ways of thinking